Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

NYSE:COUR - New York Stock Exchange, Inc. - US22266M1045 - Common Stock - Currency: USD

8.03  -0.2 (-2.43%)

After market: 8.0043 -0.03 (-0.32%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to COUR. COUR was compared to 71 industry peers in the Diversified Consumer Services industry. No worries on liquidiy or solvency for COUR as it has an excellent financial health rating, but there are worries on the profitability. COUR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
COUR had a positive operating cash flow in the past year.
In the past 5 years COUR always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: COUR reported negative operating cash flow in multiple years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

The Return On Assets of COUR (-8.55%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -13.31%, COUR is in line with its industry, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
ROA -8.55%
ROE -13.31%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

COUR's Gross Margin of 53.47% is fine compared to the rest of the industry. COUR outperforms 67.19% of its industry peers.
In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
COUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

7

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COUR has more shares outstanding
The number of shares outstanding for COUR has been increased compared to 5 years ago.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

COUR has an Altman-Z score of 2.08. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of COUR (2.08) is better than 67.19% of its industry peers.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.08
ROIC/WACCN/A
WACC10.55%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.54 indicates that COUR has no problem at all paying its short term obligations.
COUR has a better Current ratio (2.54) than 75.00% of its industry peers.
A Quick Ratio of 2.54 indicates that COUR has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.54, COUR is doing good in the industry, outperforming 76.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.54
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1788.89% over the past year.
Looking at the last year, COUR shows a quite strong growth in Revenue. The Revenue has grown by 9.28% in the last year.
Measured over the past years, COUR shows a very strong growth in Revenue. The Revenue has been growing by 30.38% on average per year.
EPS 1Y (TTM)1788.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%6.1%

3.2 Future

COUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.58% yearly.
Based on estimates for the next years, COUR will show a small growth in Revenue. The Revenue will grow by 6.05% on average per year.
EPS Next Y12.62%
EPS Next 2Y18.11%
EPS Next 3Y19.58%
EPS Next 5YN/A
Revenue Next Year4.3%
Revenue Next 2Y4.8%
Revenue Next 3Y6.05%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

3

4. Valuation

4.1 Price/Earnings Ratio

COUR is valuated rather expensively with a Price/Earnings ratio of 23.62.
COUR's Price/Earnings is on the same level as the industry average.
COUR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.63.
The Price/Forward Earnings ratio is 20.97, which indicates a rather expensive current valuation of COUR.
Based on the Price/Forward Earnings ratio, COUR is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
COUR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.62
Fwd PE 20.97
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, COUR is valued a bit cheaper than 67.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.46
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COUR does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 19.58% in the coming years.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y18.11%
EPS Next 3Y19.58%

0

5. Dividend

5.1 Amount

COUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COURSERA INC

NYSE:COUR (2/21/2025, 8:10:39 PM)

After market: 8.0043 -0.03 (-0.32%)

8.03

-0.2 (-2.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-30 2025-01-30/bmo
Earnings (Next)04-28 2025-04-28/amc
Inst Owners83.74%
Inst Owner Change-0.35%
Ins Owners5.53%
Ins Owner Change0.54%
Market Cap1.27B
Analysts76
Price Target10.18 (26.77%)
Short Float %5.31%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)224.19%
Min EPS beat(2)92.38%
Max EPS beat(2)356%
EPS beat(4)4
Avg EPS beat(4)570.54%
Min EPS beat(4)92.38%
Max EPS beat(4)1163.86%
EPS beat(8)8
Avg EPS beat(8)1340.59%
EPS beat(12)11
Avg EPS beat(12)904.7%
EPS beat(16)13
Avg EPS beat(16)682.87%
Revenue beat(2)0
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)-0.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.61%
Min Revenue beat(4)-2.75%
Max Revenue beat(4)1.57%
Revenue beat(8)5
Avg Revenue beat(8)1.06%
Revenue beat(12)8
Avg Revenue beat(12)0.71%
Revenue beat(16)11
Avg Revenue beat(16)1.49%
PT rev (1m)-3.73%
PT rev (3m)-37.3%
EPS NQ rev (1m)13.3%
EPS NQ rev (3m)26.77%
EPS NY rev (1m)10.13%
EPS NY rev (3m)11.62%
Revenue NQ rev (1m)-1.31%
Revenue NQ rev (3m)-7.68%
Revenue NY rev (1m)-2.16%
Revenue NY rev (3m)-2.22%
Valuation
Industry RankSector Rank
PE 23.62
Fwd PE 20.97
P/S 1.83
P/FCF 21.46
P/OCF 13.34
P/B 2.13
P/tB 2.22
EV/EBITDA N/A
EPS(TTM)0.34
EY4.23%
EPS(NY)0.38
Fwd EY4.77%
FCF(TTM)0.37
FCFY4.66%
OCF(TTM)0.6
OCFY7.5%
SpS4.39
BVpS3.77
TBVpS3.62
PEG (NY)1.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.55%
ROE -13.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.47%
FCFM 8.53%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 143.92%
Cap/Sales 5.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 2.54
Altman-Z 2.08
F-Score7
WACC10.55%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1788.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y12.62%
EPS Next 2Y18.11%
EPS Next 3Y19.58%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%6.1%
Revenue Next Year4.3%
Revenue Next 2Y4.8%
Revenue Next 3Y6.05%
Revenue Next 5YN/A
EBIT growth 1Y28.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year216.03%
EBIT Next 3Y73.99%
EBIT Next 5YN/A
FCF growth 1Y650.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y221.74%
OCF growth 3Y279.12%
OCF growth 5YN/A